In the next step, we assessed the effect of ghrelin treatment on the malondialdehyde (MDA) level as a marker of lipid peroxidation, catalase activity, and antioxidant capacity in the extracted hippocampus and serum of Aβ-induced AD rats. Here, GHRL is linked to Alzheimer disease.